STOCK TITAN

CollPlant: director's milestone warrants cover up to 4M

Milestone warrant exercisability is tied to three business milestones, with a separate share tranche for each milestone.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
3

Rhea-AI Filing Summary

Ruty Ben Shlomi, a director of CollPlant Biotechnologies Ltd, reported direct holdings of 66,501 ordinary shares, 105,038 pre-funded warrants, and milestone pre-funded warrants covering up to 3,999,446 ordinary shares. Both warrant holdings list an exercise price of $0.0001. The reported security amounts were adjusted to reflect the 1-for-10 reverse stock split effective September 4, 2026; milestone warrant exercisability is subject to specified business milestones.

Insider Shlomi Ruty Ben
Role Director
Type Security Shares Price Value
holding Pre-Funded Warrants to Purchase Ordinary Shares F2, F1 -- -- --
holding Milestone Pre-Funded Warrants to Purchase Ordinary Shares F3, F1 -- -- --
holding Ordinary Shares F1 -- -- --
Holdings After Transaction: Pre-Funded Warrants to Purchase Ordinary Shares — 105,038 contracts (Direct); Milestone Pre-Funded Warrants to Purchase Ordinary Shares — 3,999,446 contracts (Direct); Ordinary Shares — 66,501 shares (Direct)
Footnotes (3)
  1. F1. Effective as of September 4, 2026, the Issuer effected a 1-for-10 reverse stock split of its Ordinary Shares (the "Reverse Stock Split"). The amount of securities reported on this Form 3 has been adjusted to reflect the Reverse Stock Split.
  2. F2. The Pre-Funded Warrants remain exercisable until fully exercised.
  3. F3. The Milestone Pre-Funded Warrants become exercisable upon their issuance, subject to the achievement of specified business milestones, and remain exercisable until fully exercised. The Milestone Pre-Funded Warrants are exercisable for up to an aggregate of 3,999,446 ordinary shares, no par value, of the Issuer (the "Ordinary Shares"), with the first tranche, covering 441,683 Ordinary Shares, becoming exercisable upon achievement of the first milestone; the second tranche, covering 1,718,726 Ordinary Shares, becoming exercisable upon achievement of the second milestone; and the third tranche, covering 1,839,037 Ordinary Shares, becoming exercisable upon achievement of the third milestone, in each case subject to the terms and conditions of the Milestone Pre-Funded Warrants.
Direct ordinary shares held 66,501 shares Reported September 3, 2026
Pre-funded warrants 105,038 warrants Each warrant is exercisable for an ordinary share
Milestone pre-funded warrants 3,999,446 underlying ordinary shares Aggregate amount across three milestone tranches
Exercise price $0.0001 per share Both warrant holdings
First milestone tranche 441,683 ordinary shares Becomes exercisable upon achievement of the first milestone
Second milestone tranche 1,718,726 ordinary shares Becomes exercisable upon achievement of the second milestone
Third milestone tranche 1,839,037 ordinary shares Becomes exercisable upon achievement of the third milestone
Reverse stock split 1-for-10 Effective September 4, 2026
Pre-Funded Warrants financial
"The Pre-Funded Warrants remain exercisable until fully exercised."
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
Milestone Pre-Funded Warrants financial
"subject to the achievement of specified business milestones"
tranche financial
"the first tranche, covering 441,683 Ordinary Shares"
A tranche is one slice of a larger financing or investment that is released, sold, or paid out in separate parts rather than all at once. Investors care because each slice can carry different risk, return and timing—like buying pieces of a cake where some slices are richer or come later—so the specific tranche you hold affects when you get paid and how much you might gain or lose.
Reverse Stock Split financial
"the Issuer effected a 1-for-10 reverse stock split"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
Split Ratio 1-for-10 reverse split
Effective Date September 4, 2026

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares can CLGN's milestone pre-funded warrants cover?

They cover up to an aggregate of 3,999,446 ordinary shares in three tranches: 441,683 shares at the first milestone, 1,718,726 at the second, and 1,839,037 at the third, subject to the warrants' terms and conditions.

When can CLGN's milestone pre-funded warrants be exercised?

The milestone pre-funded warrants become exercisable upon issuance, subject to achievement of specified business milestones. The first, second, and third tranches become exercisable upon achievement of their respective milestones.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Shlomi Ruty Ben

(Last)(First)(Middle)
C/O COLLPLANT BIOTECHNOLOGIES LTD.
4 OPPENHEIMER ST, WEIZMANN SCIENCE PARK

(Street)
REHOVOT7670104

(City)(State)(Zip)

ISRAEL

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
09/03/2026
3. Issuer Name and Ticker or Trading Symbol
CollPlant Biotechnologies Ltd [ CLGN ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares66,501(1)D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Pre-Funded Warrants to Purchase Ordinary Shares09/03/2026 (2)Ordinary Shares105,038(1)$0.0001D
Milestone Pre-Funded Warrants to Purchase Ordinary Shares (3) (3)Ordinary Shares3,999,446(1)(3)$0.0001D
Explanation of Responses:
1. Effective as of September 4, 2026, the Issuer effected a 1-for-10 reverse stock split of its Ordinary Shares (the "Reverse Stock Split"). The amount of securities reported on this Form 3 has been adjusted to reflect the Reverse Stock Split.
2. The Pre-Funded Warrants remain exercisable until fully exercised.
3. The Milestone Pre-Funded Warrants become exercisable upon their issuance, subject to the achievement of specified business milestones, and remain exercisable until fully exercised. The Milestone Pre-Funded Warrants are exercisable for up to an aggregate of 3,999,446 ordinary shares, no par value, of the Issuer (the "Ordinary Shares"), with the first tranche, covering 441,683 Ordinary Shares, becoming exercisable upon achievement of the first milestone; the second tranche, covering 1,718,726 Ordinary Shares, becoming exercisable upon achievement of the second milestone; and the third tranche, covering 1,839,037 Ordinary Shares, becoming exercisable upon achievement of the third milestone, in each case subject to the terms and conditions of the Milestone Pre-Funded Warrants.
/s/ Ruty Ben Shlomi10/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Keep reading